Literature DB >> 24679666

NOD2/CARD15 and IL23R genetic variability in 204 Algerian Crohn's disease.

Y Meddour1, S Chaib1, A Bousseloub2, N Kaddache3, L Kecili3, L Gamar3, M Nakkemouche4, R Djidjik5, M C Abbadi6, D Charron7, T E Boucekkine3, R Tamouza7.   

Abstract

NOD2/CARD15 and IL23R gene variants play an important role in the susceptibility to Crohn's disease (CD). Studies of genotype-phenotype relationship suggest that these variants are associated with the development of the disease and specific phenotype. Preliminary reports analyzing the association between these variants have never been made on Algerian CD's. In a case-control design, 204 Algerian with CD diagnosed for at least 5years and 201 controls were included were genotyped for single nucleotide polymorphisms (SNP) in the NOD2/CARD15 gene R702W (SNP8, rs2066844), G908R (SNP12, rs2066845) and IL23R R381Q (rs11209026) gene variants were determined using the TaqMan SNP genotyping assays. NOD2/CARD15 908R was carried by 3% of the patients and none in control subjects (χ(2)=8.6, Pc=0.003, OR=13.20). NOD2/CARD15 702W was associated to CD outcome (χ(2)=17.2, Pc=0.00003, OR=12.5) and early onset of disease (group A1, χ(2)=19.3, Pc=1.10(-5), OR=14.05, PM-H=2.10(-6)). IL23R 381Q variants was more frequent in CD's patients than controls (χ(2)=8, Pc=0.005, OR=3.48), it was associated to earlier onset (group A1, χ(2)=7.1, Pc=0.007, OR=1.04, PM-H=0.002), extra-intestinal manifestations (EIM) outcome (χ(2)=10.6, Pc=0.001, OR=1.05, PM-H=0.002) and ileocolonic location (χ(2)=6.8, Pc=0.009, OR=1.05, PM-H=0.001). In this Algerian cohort, NOD2/CARD15 and IL23R variants were associated with CD's outcomes and linked to a particular clinical phenotype.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24679666     DOI: 10.1016/j.clinre.2014.02.003

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  7 in total

1.  NOD2/CARD15 mutations in Polish and Bosnian populations with and without Crohn's disease: prevalence and genotype-phenotype analysis.

Authors:  Nermin N Salkic; Grazyna Adler; Iwona Zawada; Ervin Alibegovic; Beata Karakiewicz; Anna Kozlowska-Wiechowska; Michał Wasilewicz; Violetta Sulzyc-Bielicka; Dariusz Bielicki
Journal:  Bosn J Basic Med Sci       Date:  2015-05-25       Impact factor: 3.363

2.  NOD2/CARD15 gene mutations in North Algerian patients with inflammatory bowel disease.

Authors:  Aziza Boukercha; Hamida Mesbah-Amroun; Amira Bouzidi; Houria Saoula; Mhamed Nakkemouche; Maryline Roy; Jean-Pierre Hugot; Chafia Touil-Boukoffa
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

Review 3.  Genetic Influences on the Development of Fibrosis in Crohn's Disease.

Authors:  Bram Verstockt; Isabelle Cleynen
Journal:  Front Med (Lausanne)       Date:  2016-05-30

4.  Circulating concentrations of interleukin (IL)-17 in patients with multiple sclerosis: Evaluation of the effects of gender, treatment, disease patterns and IL-23 receptor gene polymorphisms.

Authors:  Seyed Ali Ghaffari; Maryam Nemati; Hossain Hajghani; Hossainali Ebrahimi; Abdolkarim Sheikhi; Abdollah Jafarzadeh
Journal:  Iran J Neurol       Date:  2017-01-05

5.  Detection of mutations in NOD2/CARD15 gene in Arab patients with Crohn's disease.

Authors:  Iqbal Siddique; Abu S Mustafa; Islam Khan; Ali H Ziyab; Munira Altarrah; Riyas Sulaiman; Numeer Kadungothayil; Faraz Shaheed
Journal:  Saudi J Gastroenterol       Date:  2021 Jul-Aug       Impact factor: 2.485

6.  Association of Interleukin-23 receptor gene polymorphisms with susceptibility to Crohn's disease: A meta-analysis.

Authors:  Wang-Dong Xu; Qi-Bing Xie; Yi Zhao; Yi Liu
Journal:  Sci Rep       Date:  2015-12-18       Impact factor: 4.379

7.  Targeted Gene Sequencing in Children with Crohn's Disease and Their Parents: Implications for Missing Heritability.

Authors:  Jiun-Sheng Chen; Fulan Hu; Subra Kugathasan; Lynn B Jorde; David Nix; Ann Rutherford; Lee Denson; W Scott Watkins; Sampath Prahalad; Chad Huff; Stephen L Guthery
Journal:  G3 (Bethesda)       Date:  2018-08-30       Impact factor: 3.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.